EUVIMEDEUVIMED entdecken
Crossref

Lipid Droplet-Targeted NIR Polarity Probe for the Imaging of Acute Asthma In Vivo

Mingyue Li, Yanmei Zhu, Linlin Hu iD, Jun Li, Jiyoung Yoo, Huamei Zhang, Zhaosheng Qian iD, Xucong Zhou iD, Jong Seung Kim iD, Jin Zhou iD

Journal of Medicinal Chemistry · 24.07.2025 · 68 (14) · 15165-15175

DOI: 10.1021/acs.jmedchem.5c01403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 11.07.2025. Verfasst von Mingyue Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261053, China. Hauptthemen laut MEDLINE: Asthma, Fluorescent Dyes, Lipid Droplets. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Research Foundation of Korea, Taishan Scholar Project of Shandong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polarity changes are significant indicators during inflammation. Acute lung injury (ALI) and asthma, both inflammatory lung diseases, necessitate the detection of these polarity changes for early diagnosis and treatment monitoring. We designed and synthesized a lipid droplet-targeting, polarity-dependent near-infrared fluorescent probe, MY-1, on the basis of an intramolecular charge-transfer mechanism to noninvasively detect these inflammatory conditions. The probe exhibits a consistent decrease in fluorescence intensity with an increase in solvent polarity, demonstrating excellent photostability and biocompatibility. Utilizing MY-1, we can differentiate between normal cells and cancer cells and successfully detect polarity changes targeting lipid droplets within the lungs of mice suffering from ALI and asthma. Furthermore, we can monitor the therapeutic effects of dexamethasone on asthmatic mice, confirming the clinical application potential of MY-1 . In summary, we believe that MY-1 offers a novel and effective approach to the diagnosis of acute ALI and asthma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaFluorescent DyesLipid DropletsAnimalsMiceHumansAcute Lung InjuryOptical ImagingMice, Inbred BALB CDexamethasone

Substanzen

Fluorescent DyesDexamethasone

Autor:innen und Institutionen

  • School of Pharmacy, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261053, China.
  • Weifang People's Hospital, Shandong Second Medical University, Weifang 261000, China.
  • Department of Chemistry, Korea University, Seoul 02841, South Korea.
  • College of Chemistry and Materials Science, Zhejiang Normal University, Jinhua 321004, China.

ORCID-Profile: Linlin Hu, Zhaosheng Qian, Xucong Zhou, Jong Seung Kim, Jin Zhou

Förderung

  • National Research Foundation of Korea
  • Taishan Scholar Project of Shandong Province
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • Weifang Science and Technology Development Plan Project

Zitieren

APA

Li, M., Zhu, Y., Hu, L., Li, J., Yoo, J., Zhang, H., Qian, Z., Zhou, X., Kim, J. S., & Zhou, J. (2025). Lipid Droplet-Targeted NIR Polarity Probe for the Imaging of Acute Asthma In Vivo. Journal of Medicinal Chemistry, 68(14), 15165-15175. https://doi.org/10.1021/acs.jmedchem.5c01403

Vancouver

Li M, Zhu Y, Hu L, Li J, Yoo J, Zhang H, et al. Lipid Droplet-Targeted NIR Polarity Probe for the Imaging of Acute Asthma In Vivo. Journal of Medicinal Chemistry. 2025;68(14):15165-15175. doi:10.1021/acs.jmedchem.5c01403

BibTeX
@article{Li2025,
  author = {Li, Mingyue and Zhu, Yanmei and Hu, Linlin and Li, Jun and Yoo, Jiyoung and Zhang, Huamei and Qian, Zhaosheng and Zhou, Xucong and Kim, Jong Seung and Zhou, Jin},
  title = {Lipid Droplet-Targeted NIR Polarity Probe for the Imaging of Acute Asthma In Vivo},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  volume = {68},
  number = {14},
  pages = {15165--15175},
  doi = {10.1021/acs.jmedchem.5c01403}
}
Kostenlos starten →